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Abstract.  In neuronal growth cones, the advancing 
tips of elongating axons and dendrites, specific protein 
substrates appear to undergo cycles of posttranslational 
modification by covalent attachment and removal of 
long-chain fatty acids. We show here that ongoing 
fatty acylation can be inhibited selectively by long- 
chain homologues of the antibiotic tunicamycin, a 
known inhibitor of N-linked glycosylation. Tunicamy- 
cin directly inhibits transfer of palmitate to protein in 
a cell-free system, indicating that tunicamycin inhibi- 
tion of protein palmitoylation reflects an action of the 
drug separate from its previously established effects on 
glycosylation. Tunicamycin treatment of differentiated 
PC12 cells or dissociated rat sensory neurons, under 
conditions in which protein palmitoylation is inhibited, 
produces a prompt cessation of neurite elongation and 
induces a collapse of neuronal growth cones. These 
growth cone responses are rapidly reversed by washout 
of the antibiotic, even in the absence of protein syn- 
thesis, or by addition of serum. Two additional lines 
of evidence suggest that the effects of tunicamycin on 
growth cones arise from its ability to inhibit protein 
long-chain acylation, rather than its previously estab- 
lished effects on protein glycosylation and synthesis. 
(a) The abilities of different tunicamycin homologues 
to induce growth cone collapse vary systematically 
with the length of the fatty acyl side-chain of 
tunicamycin, in a manner predicted and observed for 
the inhibition of protein palmitoylation. Homologues 
with fatty acyl moieties shorter than palmitic acid (16 
hydrocarbons), including potent inhibitors of glycosy- 
lation, are poor inhibitors of growth cone function. (b) 
The tunicamycin-induced impairment of growth cone 
function can be reversed by the addition of excess ex- 
ogenous fatty acid, which reverses the inhibition of 
protein palmitoylation but has no effect on the inhibi- 
tion of protein glycosylation. These results suggest an 
important role for dynamic protein acylation in growth 
cone-mediated extension of neuronal processes. 
p 
ROTEIN modification  by the covalent  attachment of 
fatty acids is a ubiquitous  process whose biological 
significance  remains obscure (Grand,  1989; James 
and Olson, 1990; Sdamidt, 1989). Two major classes of fatty 
acylation have been identified-cotranslational, stable link- 
age of myristic acid (14 carbons)  to the NH2 terminus of 
certain proteins, and posttranslational  attachment of palmi- 
tic acid (16 carbons) and other long-chain fatty acids.  The 
latter modification can be subdivided into early posttransla- 
tional acylation and a later component, independent of pro- 
tein synthesis, that is both dynamic and sensitive to extracel- 
lular stimuli (Bourguiguon et al., 1991; Huang, 1989; James 
and Olson,  1989; Magee et al.,  1987; Skene and Virag, 
1989; Staufenbiel,  1988) and is particularly prevalent in pro- 
teins known to be involved in cellular adhesion,  signaling, 
and growth regulation  (James and Olson,  1990). This dy- 
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narnic, posttranslational  turnover of fatty acyl residues,  by 
analogy to the reversible phosphorylation  of proteins,  may 
serve to control or modify proteins subserving a variety of 
cellular functions. 
One well-defined site of  posttranslational protein acylation 
is the motile growth cone apparatus that form the advancing 
tips of elongating neuritic processes (Skene and Virag, 1989) 
and mediate the extension of axons and dendrites both in 
neuronal development and in nerve regeneration (Harris et 
al.,  1987; Sretavan and Reichardt,  1993). Elongation pro- 
ceeds through cycles of  filopodial or lamellipodial extension, 
consolidation  of selected filopodia by membrane insertion 
and cytoskeletal assembly, and retraction of unconsolidated 
filopodia  (Forscher and Smith,  1988; Goldberg  and Bur- 
meister,  1989; Okabe and Hirokawa, 1991). Regulation and 
guidance of  nerve growth are mediated by growth cone inter- 
actions with a broad array of specific ligands in the local en- 
vironment (Jessell,  1988; Mason,  1985), including  many 
that enhance growth mechanisms and others that are pro- 
posed to guide or direct neurite extension through spatially 
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Bonhoeffer, 1992; Davies et al., 1990; Moorman and Hume, 
1990;  Patterson,  1988;  Raper  and  Kapfhammer,  1990; 
Schwab and Schnell, 1991). Because growth cones from de- 
veloping brain have been shown to carry out active protein 
fatty acylation  independent  of neuronal cell bodies (Skene 
and Virag,  1989), we were particularly interested in inves- 
tigating the role of fatty acylation in mechanisms of growth 
cone-mediated axonal elongation. 
Elucidation  of  biological  roles  for  palmitoylation  in 
growth cone functions,  or in other cellular  processes, has 
been hindered by the lack of an inhibitor that would permit 
direct experimental  manipulation of this modification  in in- 
tact cells. The nucleoside antibiotic tunicamycin (TM) * (see 
Fig.  1 A) has been used extensively to investigate the role of 
protein N-linked glycosylation in protein processing, recep- 
tor activation,  viral  multiplication  and  such cellular  pro- 
cesses as division, differentiation, and adhesion (reviewed in 
Elbein,  1984;  Hemming,  1982).  However,  in some cases 
TM also has been found to interfere with the intracellular 
targeting of non-glycosylated proteins, including the appear- 
ance in a membrane fraction of newly synthesized  GAP-43, 
a  major  component of neuronal  growth  cones  (Perrone- 
Bizzozero and Benowitz, 1987). Because membrane associ- 
ation  of GAP-43  follows  the  posttranslational  transfer of 
palmitate residues (Chapman ct al., 1992; Skene and Virag, 
1989), we considered the possibility that TM might disrupt 
GAP-43 processing by interfering with long-chain acylation. 
Structural comparison shows that TM, which comprises a 
family of closely related compounds, does bear some overall 
similarity to fatty acyl coenzyme-A, the acyl donor for pro- 
tein fatty acylation (see Fig. 1 A). This raises the possibility 
that one or more of the TMs might act as a general competi- 
tive inhibitor  of protein acylation. 
Materials and Methods 
Materials 
TM homologues were prepared by HPLC (Mahoney and Duksin,  1980) 
from whole TM (Boehringer  Mannheim Corp.,  Indianapolis, IN)  by  separa- 
tion on a 4.6 x 250-ram Dynamax column packed with 5 #m Microsorb-C8 
(Rainin Instr. Co., Woburn,  MA) ehited isocratically with methanol/H20 
(68:32, HPLC grade) at 40°C. For experiments,  TM and homolngues were 
dissolved  at 1 mg/ml in 10 mM NaOH, and the concentration confirmed 
by absorbance at 260 nm after dilution into culture medium (0.12 A.U.  -- 
10 #g/ml).  The dissolved drugs were stored at  -80°C between experi- 
ments, and used within one month of preparation. 
3H-palmitoyl--coenzyme  A  was  prepared from [3H]palmitate  (60 Ci/ 
retool; Dupont NEN, Boston, MA) by incubation with 1 U/ml long-chain 
acyl:coenzyme A tramferase (Boohringer Maunheim Corp.) in 100 #1 of 
0.05%  ~riton X-100,  1 rnM coonzyme A  (CoA; Boehringer Mannheim 
Corp.), 5 mM ATE 5 mM MgC12, 10 mM Tris, pH 7.5. Reactions  were 
terminated after 1-2 h by addition of 1 ml chloroform/methanol (1:1), and 
product was isolated in the upper phase after addition of 0.5 ml chloroform 
and 0.275  ml H20.  A~ar drying, label was redissolved in methanol, all- 
quoted into reaction tubes, and dried in a Speed-Vat centrifugal evaporator 
(Savant Instr., Inc., Farmingdale,  NY).  Analysis by TLC showed  ~95 % 
radiochemical purity. 
For addition to cell cultures, radioactive and non-radioactive fatty acids 
were dissolved in DMSO and added to medium at a final concentration of 
0.1% (vol/vol) DMSO, with brief bath sonication for higher concentrations 
of fatty acid (>10 ~,M). 
1. Abbreviations used in thispaper: CoA, coenzyme A; DRG, dorsal root 
ganglion;  HE,  10 mM Hepes/1  mM EDTA;  PPO,  2,5-diphenyloxazole; 
TM, tunicamycin. 
Growth Cone Preparation and Labeling 
Intact growth cones were prepared from 3-5-d neonatal Sprague-Dawley 
rat pups by the Ficoll flotation method of Gordon-Weeks (Gordon-Weeks, 
1987, 1991; Gordon-Weeks and Lockerbie, 1984). These growth cones were 
labeled by resuspending in Hepes-buffered  DME containing 100 #Ci/ml 
[3I-I]palmitate (60 Ci/mmol) for 20 min at 37°C.  Labeling was quenched 
with 10 volumes  of chloroform/methanol (1:1). Washed membranes were 
prepared from intact growth cones by lysis in 10 mM Hepes/l mM EDTA, 
pH Z4, (HE) followed by centrifugation at 140,000 gav for 30 min. Pellets 
were washed sequentially with 1 M NaCI in HE (two washes) and then again 
with HE (one wash), with careful trituration through a 22-gange hypoder- 
mic needle.  Washed membrane protein concentration was adjusted  to  1 
mg/ml and sohibilized in 0.1% (wt/vol) Lubrol-PX (Sigma Chemical Co., 
St.  Louis,  MO) in 100 mM KC1, 20 mM NaCI, 0.1 mM MgCI2, 20 mM 
Hepes, pH 7.4, for 60 rain on ice. Insoluble material was pelleted as above. 
Aliquots (100  /tl) of supernatant were added to tubes containing dried 
3H-palmitoyl-CoA  and TM, mixed vigorously,  incubated at 37°C  for 20 
rain, and labeling reactions were quenched by the addition of 10 volumes 
chloroform/methanol (1:1). 
Cell Culture and Labeling 
PC12 cells were propagated  in DME supplemented with 5% horse serum 
and 5 % supplemented calf serum (GIBCO BRL, Gaitbersburg,  MD). Neu- 
ronal phenotype was induced by treatment with 50 ng/ml nerve growth fac- 
tor  (NGF;  tissue culture  grade,  Boehringer-Mannheim Corp.)  for not 
less than 4 d or more than 14 d. Cells for labeling were washed free of serum 
and incubated with labeled precursors of protein myristoylation  ([3H]- 
myristate, 50 #Ci/ml), long chain acylation ([3H]palmitate,  1 ~tCi-1 mCi/ 
ml), glycusylation  ([3H]mannose,  50 #Ci/ml, all from Dupont NEN), or 
synthesis  ([35S]cysteine, 50-500  #Ci/ml)  (Amersham Corp.,  Arlington 
Heights, IL) for 2 h (total cellular protein labeling) or 1 h (all figures shown) 
at 37°C in I rul DME supplemented with 10 mM Hepes, pH 7.4, 50 ng/ml 
NGF, and 0.5 ~g/ml fatty acid-free BSA (Sigma Chemical Co.).  Labeling 
reactions were quenched by adjusting the medium to 10% (wt/vol) trichlo- 
roacetic acid ([3H]mannose  and [asslcysteine),  or replacing the medium 
with methanol ([3H]myristate  and [3H]palmitate;  Juguelin and Cassngne, 
1984; Schraidt and Lambrecht, 1985). In early experiments (see data in Fig. 
3),  intact cells were pretreated with TM for 60 rain before addition of 
[3H]palmitate, but this was subsequently found to be unnecessary (see Fig. 
3  C, inset) and label and inhibitor were thereafter added together. 
Dorsal root ganglion (DRG) cultures were prepared by a modification of 
the technique of Lindsay (Lindsay, 1988) from adult male Sprngue-Dawley 
rats  (Charles River Laboratories,  Wilmington,  MA)  after a  unilateral 
sciatic nerve crush performed as previously described (Schreyer and Skene, 
1991; Skene and Shooter, 1983) under ketamineJchloral hydrate anaesthesia 
in accordance with National Institutes of Health guidelines.  After at least 
48 h, animals were killed by CO2 asphyxiation,  and the fourth and fifth 
lumbar ganglia from the operated side were excised, cut open, and collected 
in 1.5 ml L14 medium (GIBCO BRL) containing N1 supplements  (5 #g/ml 
transferrin, 5 #g/ml insulin, 16 #g/ml potrescine, 30 nM sodium selenite, 
20 nM progesterone,  all from Sigma Chemical Co.) and 50 ng/mi NGF in 
35-ram tissue culture dishes (Coming Inc., Medfield, MA) on ice. Ganglia 
were washed twice in 1.5 ml prewarmed medium, then incubated for 90 rain 
at 37°C in a further 1.5 ml F14 containing N1 additives, NGF and 3.0 #g/ml 
collagenase  (type XI), followed by trituration through a flamed pasteur pi- 
pette.  Cell dissociation was completed by 15 rain with 0.3 rag/rot trypsin 
(type XII-S), l0 rain with 0.I mg/ml deoxyribonuclcase  I (type IV), 5 rain 
in 5 mM EDTA and finally further trituration. Dissociated cells were trans- 
ferred to a 15-rul conical tube, adjusted to 0.3 m_g/ml  soybean trypsin inhibi- 
tor (all from Sigma Chemical Co.) and 5% horse serum, and pelleted. Cells 
were washed twice with 10 mi medium with gentle centrifngation between, 
before being plated in F14 medium containing N1 additives and 5% horse 
serum at a density of one-fifth to one-tenth ganglion/35-mm  dish, precoated 
with polyornithine (Sigma Chemical Co.) and laminin (Upstate Bintech- 
nology, Lake Placid, NY) according to manufacturers'  recommendations. 
Labeling with [3H]-palmitate  was carried out as for PCI2 cells. 
Protein Analysis 
Cells labeled with [3H]mannose or [35S]cysteine were  scraped into 10% 
(wt/vol) trichinroacctic acid and left on ice for 1 h. Insoluble material was 
pelleted at 12,000 g for 15 rain, fol/owed by sequential washes with 10% 
and 1% trichloroacetic acid, and ether. The remaining material was solubi- 
lized in 1% SDS in 100 mM Tris.HC1, pH 7.4, with heating, and radioactiv- 
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cells with [3H]myristate or [3H]palmitate, cells were scraped into metha- 
nol, transferred and adjusted to chloroform/methanol/H20 (5:5:1).  After 
extraction for 1 h, insoluble material was pelleted at 12,000 g for 15 min, 
followed by sequential 1 h washes (3-6) in chloroform/methanol/H20 until 
no  further  radioactivity  was  extracted,  then  two  washes  with  chloro- 
form/methanol (2:1), solubflization and counting as above. Data given were 
from 5  (13I-l]myristate),  4  ([3H]palmitate,  [3H]mannose),  or 3  ([35S]cys- 
teine) independent experiments. 
For analysis of specific cellular proteins, labeled cells were scraped into 
methanol,  transferred  to  polypropylene  tubes,  and  adjusted  to  chloro- 
form/methanol/H20  (5:5:1).  After pelleting as  above,  the proteins were 
redissolved in sample buffer containing 1% SDS,  10 mM Tris, pH 7.4, and 
20%  glycerol  with heating,  and separated on  12%  SDS/polyacrylamide 
gels. Two-dimensional gel analysis was carried out with ampholytes in the 
range 3-10 and 4-6 (Bio Rad Laboratories, Hercules, CA) at a ratio of 2:1. 
For  immunoprecipitation of labeled GAP-43  from washed growth cone 
membranes,  material was  solublized in 0.1%  Lubrol-PX in HE,  and in- 
cubated overnight at 4"C with the monoclonal antibody 9-1E12  (Schreyer 
and Skene,  1991)  preadsorbed onto agarose-immobilized goat antimouse 
IgG (HyClone Laboratories,  Logan,  UT).  Proteins were fixed in the gel 
with 25% isopropanol/10% acetic acid and permeated with 2,5-diphenyl- 
oxazole  (PPO;  Sigma  Chemical  Co.;  1%  wt/vol  in  15%  ethanol/30% 
xylenes/55 % acetic acid) for fluorography. The identification of the major 
3H-palmitoylated protein in growth cones as GAP-43 has been published 
elsewhere (Skene and Virag, 1989), and the identity of SNAP-25 and GAP- 
43  in DRG  neurons  was  confirmed by the  migration position  on  two- 
dimensional gels (Hess et al.,  1993).  The major labeled protein in PC12 
cells was shown to be SNAP-25 by two-dimensional gel analysis, while 
GAP-43 labeling in PC12 cells varied considerably with culture conditions, 
and could not always be seen. 
Lipid Analysis 
Cells labeled with [3H]-palmitate were extracted with chloroform/metha- 
nol/H20 as described above. Aliquots of the first organic extract (1/10 of 
total volume) were dried in Speed-Vac,  redissolved in chloroform/methanol 
(2:1)  and  separated  by  TLC  on  aluminum-backed  silica  gel  plates 
(Art.5553;  EM Science,  Gibbstown,  NJ)  developed with butanol/acetic 
acid/H20 (5:2:3, Jnguelin and Cassagne, 1984). After drying, plates were 
permeated with PPO (10% wt/vol in ether) for fluorography. 
Quantitation of  Radioactivity 
PPO-perrneated gels or TLC plates were exposed for various lengths of time 
at -70"C to x-ray film (X-OMAT AR; Eastman Kodak Co., Rochester, NY) 
preflashed to an optical density of 0.I A.U. After development, bands were 
identified by reference to protein molecular weight or lipid standards, and 
quantitated by transmittance optical density on a Technology Resources im- 
age analysis system. 
For experiments using solubilized protein acylating activity from growth 
cones, the labeling of protein was expressed as the ratio of the amount of 
label incorporated into GAP-43 compared with the amount remaining in 
palmitoyl-CoA at the end of the incubation in the same sample. This was 
done as lipid analysis showed a substantial accumulation of labeling precur- 
sor, 3H-palmitoyl-CoA, in the presence of high concentrations of TM, pre- 
sumably due to disruption of incorporation into lipid. Therefore, in these 
experiments, the ratio of product/precursor  was used to adjust for more 
efficient protein labeling due to precursor protection. The unadjusted range 
of labeling inhibition by TM can be seen by comparing lanes 2  and 3  in 
Fig.  lB. 
Itme-Lapse Video Microscopy 
Cells for video recording were plated on polyornithine/laminin-coated 35- 
mm tissue culture dishes. PC12 cells were differentiated with NGF as de- 
scribed above. DRG cultures were taken 8 h-3 d after plating. Cells were 
washed free of serum with the appropriate bicarbonate-free, Hepes-buffered 
medium containing 50 ng/ml NGF and 0.5 #g/ml fatty acid-free BSA, and 
N1 additives (DRG cells only). Cells in 2 ml medium were transferred to 
a temperature controller (Narashige model MS-200D) mounted on an in- 
verted stage microscope (Nikon Diaphot-TMD) and maintained at 37"C. 
Growth cones were observed with Hoffrnan modulation contrast optics con- 
nected  to  a  charge-coupled  device  camera  (MTI  model  CCD72S)  and 
recorded on S-VHS tapes using a time-lapse recorder (Panasonic 6750A). 
Prints were subsequently made from the tapes using a video printer (Sony 
UP-3000). 
Results 
TM Inhibits Solubilized Protein Acylating Activity 
from Growth Cones 
To explore the possibility that TM could inhibit protein acy- 
lation directly, we prepared a detergent-solubilized  fatty acyl- 
CoA:protein acyltransferase activity from neuronal growth 
cones (Fig. 1 B, lanes I and 2). Because these structures oc- 
cur at the ends of elongating axons and dendrites, at some 
distance from neuronal cell bodies, they can be isolated as 
a  sub-cellular fraction substantially free of the cellular ap- 
paratus  for protein  synthesis and glycosylation (Gordon- 
Weeks,  1987, 1991; Gordon-Weeks and Lockerbie,  1984; 
Pfenninger et al., 1983). Such isolated growth cones can in- 
corporate externally added [3H]-palmitate  into endogenous 
protein substrates (Fig.  1 B), the most prominent of which 
has been identified previously as GAP-43 (Skene and Virag, 
1989).  Isolated growth cones therefore provide a potential 
source of protein palmitoylating enzyme(s) for mechanistic 
studies. 
Membranes prepared from isolated neuronal growth cones 
and extensively washed to remove peripherally bound pro- 
teins retain a protein fatty acyltransferase activity, which can 
be solubilized in nonionic detergent (Fig. 1 B). This activity 
labels endogenous GAP-43 by transfer of palmitic acid from 
exogenously added 3H-palmitoyl-CoA, the immediate pre- 
cursor of protein acylation (Riendeau and Guertin,  1986). 
TM caused a dose-dependent inhibition of this final step of 
GAP-43  palmitoylation (Fig.  1 C). 
Immunoprecipitation confirmed the identity of the major 
endogenous protein palmitoylated in washed growth cone 
membranes as GAP-43 (Fig. 2). Because virtually all of the 
GAP-43 remaining associated with these extensively washed 
membranes would be expected to be palmitoylated  before the 
labeling reaction (Liu et al., 1991; Skene and Virag, 1989), 
it is likely that active de-acylation of GAP-43 occurs under 
our reaction conditions. We therefore cannot exclude the 
possibility that TM interferes with deacylation of GAP-43 to 
serve as a  substrate  for reacylation, rather than with the 
palmitoylating enzyme.  The  results  nevertheless  demon- 
strate that some component of TM can inhibit directly the 
cycle of protein acylation and deacylation in growth cones, 
and thus can serve as a pharmacological probe for the biolog- 
ical functions of this dynamic modification in intact cells. 
The amount of TM required to produce a 50% inhibition 
of palmitoylation in the solubilized preparation under our 
standard reaction conditions was relatively high (>250/~g/ 
mi), but decreased as the amount of added 3H-palmitoyl- 
CoA was reduced (Fig.  1 C). Although these data are not 
adequate to establish a competitive mechanism of  inhibition, 
it does illustrate that the inhibitory effect of TM on protein 
palmitoylation depends on the concentration of the fatty acyl 
donor. The local concentration of palmitoyl-CoA in intact 
growth cones in vivo or in vitro is not known, but fatty acyl- 
Cogs in most cells are present in only trace amounts (Molap- 
arast-Saless et al.,  1988).  Even the lowest concentration of 
labeled palmitoyl-CoA used in our reactions, therefore, is 
likely to exceed the concentration of endogenous palmitoyl- 
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ity from neuronal growth cones. (,4) Comparison of the structures 
of TM (top, homologue C2) and palmitoyl coenzyme A (bottom, 
in extended configuration). TM comprises a  family of closely 
related homologues that differ in the fatty aeyl side chain; homo- 
logue C2, one of the more abundant homologues with a 16-carbon 
aeyl chain, is illustrated. (B) Incorporation of 3H-palmitate into 
specific proteins by intact isolated growth cones from neonatal rat 
brain  (lane 1)  and by a detergent-solubilized preparation from 
washed growth  cone membranes (lanes 2 and 3). Protein palmitoy- 
lating activity evident in the solubilized preparation (lane 2) is 
strongly inhibited in the presence of 1 mg/ml TM (lane 3). Intact 
growth cones were labeled with  1.7 #M 3H-palmitic acid,  and 
solubilized preparations were labeled with 1.7 #M 3H-palmitoyl- 
CoA. Incubations were for 20 rain at 37"C. The arrow marks the 
most prominent substrate for palmitoylation, GAP-43 (Skene and 
Virag, 1989; and see Fig. 2). Coomassie  blue staining indicates  that 
the total amount of the GAP-43 substrate is unaffected  by the pres- 
ence of TM (not shown). (C) Effect  of TM on protein palmitoylat- 
ing activity at three concentrations of palmitoyl-CoA. Solubilized 
growth cones were  treated  with  initial  concentrations of 3H- 
palmitoyl-CoA  of 17 nM (circles), 170 nM (squares) or 1.7 gM (tr/- 
angles) for 20 rain at 37"C with increasing concentrations of TM, 
and labeled GAP-43  palmitoylation  was quantitated and normalized 
to paimitoyl-CoA levels as described in Materials and Methods. 
The results are presented as means +  range for two independent 
experiments. Analysis by two factor ANOVA (Statview II; Abacus 
Concepts, Inc., Berkeley,  CA) shows  that the results at 17 nM and 
1.7 #M 3H-palmitoyl-CoA  are significantly different (P < 0.05). 
CoA found in growth cones of intact cells, and the amount 
of TM required to inhibit protein palmitoylation in intact 
growth cones would be expected to be equal to or lower than 
that determined with the lowest concentration of exogenous 
palmitoyl-CoA in the solubilized preparation. 
TM Inhibits Posttranslational Protein Palmitoylation 
To characterize the effects of TM on protein acylation in an 
intact cellular environment, we analyzed the incorporation 
of palmitic acid into proteins of cultured DRG neurons from 
adult rats and differentiated PC12 cells (Olson et al., 1985), 
neuron-like tumor cells that extend processes with active, 
motile growth cones. Both of these cell types incorporated 
palmitate into a number of cellular proteins (Fig. 2). Two of 
these substrate proteins have been identified as GAP-43 and 
SNAP-25  (Hess et al., 1992,  1993). The relative labeling of 
these two proteins differs between dissociated adult DRG 
neurons and PC12 cells (Fig. 2), and among PC12 cells un- 
der  different conditions  (not  shown),  possibly  reflecting 
differential expression of GAP-43 and SNAP-25  in associa- 
tion with different stages of axonal elongation, arborization 
and synaptogenesis (Osen-Sand et al.,  1993;  Oyler et al., 
1991; Simkowitz et al., 1989; Skene, 1989). TM at 10/~g/ml 
inhibited palmitoylation of  both of these proteins by 47-65 % 
(Fig. 2). Labeling of other cellular proteins was inhibited to 
a similar extent, without obvious selectivity for individual 
substrate proteins (Figs. 2 and 3 A). For this reason, the most 
robustly and consistently labeled proteins in each cell type, 
GAP-43 in DRG neurons and SNAP-25  in PC12 cells, were 
used for quantitative analysis. 
As in other cells (Bourguignon et al., 1991; James and Ol- 
son,  1989;  Magee et al.,  1987; Skene and Virag,  1989; 
Staufenbiel, 1988) protein palmitoylation in PC-12 cells has 
a  late posttranslational component, indicated by the large 
fraction (38%)  of total protein labeling by [3H]-palmitate 
that persists after treatment with cycloheximide, a specific 
inhibitor of protein synthesis (Fig. 3 A). Under similar con- 
ditions, TM at 20 #g/ml displayed a strong inhibition of  total 
cellular  protein  glycosylation (70%)  and  paimitoylation 
(50%), which were reduced by a larger increment (P < 0.02, 
Student's unpaired t-test) than could be accounted for simply 
by the observed inhibition of protein synthesis (10%,  data 
not shown). It has been suggested that translation-dependent 
and  -independent palmitoylation reflect,  respectively, the 
initial processing of proteins in the Golgi and later turnover 
of fatty acid moieties on proteins at the plasma membrane 
(Gutierrez and Magee,  1991; Olson,  1988).  We found that 
TM  inhibition of the late posttranslational component of 
palmitoylation (45%  at  10  gg/ml TM)  was  significantly 
greater than its inhibition of  total cellular protein palmitoyla- 
tion (28%,  P  <  0.05, seven independent trials; Fig. 3 B). 
This indicates that, under these assay conditions, the effects 
of  TM on total cellular protein palmitoylation  reflect primar- 
ily a strong inhibition of the late posttranslational compo- 
nent, with less potent inhibition of acylation occurring in 
concert with translation. 
In either the presence or absence of cycloheximide, TM 
produced no significant inhibition of [3H]-palmitate  incor- 
poration  into ceUular  lipids  (P >  0.05, four independent 
trials; Fig. 3, A and B). A modest inhibition (22 %) of  protein 
myristoylation was observed with 20 gg/ml TM (data not 
shown), but this was not significantly greater than the inhibi- 
tion of protein synthesis (P > 0.05),  and may be an indirect 
consequence of the tight coupling of myristoylation  to trans- 
lation (Buss et al.,  1984; Wilcox and Olson, 1987).  These 
results indicate that TM does not interfere equally with all 
cellular reactions that depend on acyl-CoAs as a fatty acid 
donor,  but is  relatively specific for  one or more protein 
The Journal  of Cell Biology,  Volume 124, 1994  524 Figure 2. TM inhibits general and growth cone protein palmitoylation in intact neuronal cells. Washed  growth cone (GC) membrane pro- 
teins labeled with 3H-palmitoyl-CoA were separated on one-dimensional SDS-PAGE (lane 1) or immunoprecipitated with an anti- 
GAP-43 monoclunal antibody and run in a parallel lane (lane 2). Intact cultured DRG neurons and NGF-differentiated  PC12 cells were 
labeled with 3/~M [3H]palmitate with or without 10/~g/ml TM for 60 min in culture. Both cell types incorporate label into a range of 
proteins of different molecular masses (standards from top to bottom: 106, 80, 49.5, 32.5, 27.5, and 18.5 kD). The heavily labeled band 
in the DRG samples (lanes 1 and 2) migrating in the same position as the growth cone GAP-43 immunoprecipitate has been identified 
as GAP-43 on two-dimensional gels (Hess et al.,  1993), and under these conditions incorporates 65  +  11% less label in the presence 
of  TM (lane 2). The labeled protein migrating  just above  the 27.5 kD standard in both DRG and PC12 cells (arrowheads)  has been identified 
as SNAP-25 by two-dimensional  gel analysis (Hess et al., 1993 and above), and its labeling is inhibited by 57 +  15% in DRG neurons 
and, in the experiment shown here, by 47% in PC12 cells. 
acyltransferase(s) involved in posttranslational palmitoyla- 
tion. 
As in the acyltransferase preparation,  TM inhibition of 
protein palmitoylation  in intact cells was dose dependent, al- 
though an equivalent inhibition of palmitoylation required a 
lower dose of TM in intact cells than in the cell-free system 
(compare Figs. 1 C and 3 C). This may reflect the low intra- 
cellular levels of palmitoyl-CoA in intact cells (Fig.  3 A), 
compared with the  substantial amount of palmitoyl-CoA 
added to the cell-free acyltransferase preparation. 
Routine quantitation of TM effects on protein palmitoy- 
lation was  carried  out with 60  rain  exposure  of cells  to 
[3H]-palmitate  to permit uptake and conversion of labeled 
palmitic acid to palmitoyl-CoA and subsequent incorpora- 
tion of sufficient label for reliable quantitation. The use of 
shorter time points resulted in low and variable levels of  pro- 
tein labeling. Nevertheless, we attempted to estimate how 
rapidly TM was able to exert its inhibitory effect on protein 
palmitoylation in intact cells.  Cells were prelabeled with 
pH]-palmitate for 20 rain, and then labeling was continued 
in the presence or absence of 10/,g/nil TM for an addi- 
tional 20 rain. In the absence of TM, incorporation of [~H]- 
palmitate was linear throughout the 40-min labeling period. 
Best-fit regression analysis indicates, however, that the rate 
of incorporation in the presence of TM was reduced by 49 % 
over the 20 min period following addition to intact cells (Fig. 
3  C, inset). This reduced rate of palmitoylation at shorter 
times after TM addition is comparable with the 45 % inhibi- 
tion observed after a standard 60-min incubation (Fig. 3 B). 
A 49 % reduction in palmitoylation  over the first 20 rain after 
TM  addition indicates  that palmitate  incorporation must 
have  been  inhibited  for  the  majority  of the  application 
period.  Extrapolation of the best-fit regression curve sug- 
gests that the rate of palmitate incorporation may decrease 
within 5  min after addition of TM to the medium. Thus, 
while difficulty in quantifying [3H]-palmitate  incorporation 
after short labeling intervals prevents a precise estimate, TM 
appears  to produce  a  reduction in protein palmitoylation 
within 5-10 min of application to cultures of intact cells. 
TM Rapidly Collapses Neuronal Growth Cones 
The ability of TM to inhibit posttranslational protein palmi- 
toylation in intact cells makes it a useful reagent for explor- 
ing the roles of  protein fatty acylation in normal growth cone 
functions.  In  culture,  the active,  motile growth cones  of 
differentiated  PC12 cells (Okabe and Hirokawa, 1991) can be 
followed individually using  time-lapse  video microscopy 
(Fig. 4).  Within 10 rnin after addition of TM to such cul- 
tures, growth cones ceased to grow forward and "collapsed" 
to form rounded retraction profiles that are brighter in both 
modulation-contrast and phase-contrast optics,  often with 
the appearance  of multiple varicosities along the neurite 
shaft. In the continuous presence of TM the neurite would 
subsequently retract (Fig. 4 A); however, washout of TM re- 
sulted in a rapid return of forward mobility (Fig. 4 B). 
This rapid growth cone collapse and impairment of  neurite 
elongation in response to TM should be distinguished from 
a much later (1-6 d) effect  of  TM on neurite extension, which 
has  been  attributed  to  a  prolonged  blockade  of protein 
glycosylation  (Heacock, 1982; Richter-Landsberg and Duk- 
sin,  1983).  In addition to its much slower time course, the 
late inhibition of neurite growth was observed  in culture 
medium containing serum. Previous studies in retinal neu- 
rons and non-neuronal cells indicate that TM inhibition of 
N-linked glycosylation  may become apparent only after a lag 
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toylation in differentiated PC-12 cells.  (A) Representative fluoro- 
grams of protein and lipid labeling in the presence or absence of 
10 /~g/ml TM.  The posttranslational  component  of labeling  was 
measured in the presence of 100 #g/ml cycloheximide (cyclo). Cells 
were preincnhated  with the indicated additions for 60 min before 
the addition of 3 #M [3H]palmitate for a further 60 rain. Proteins 
were separated  by 12%  SDS-PAGE (left panel),  and lipids were 
analyzed by thin-layer chromatography  (right  panel).  The migra- 
tion positions of free fatty acid (FFA), phosphatidylcholine  (PC), 
and palmitoyl-CoA (Palm-CoA) standards are indicated on the TLC 
fluorogram. (B) Quantitation of the effect of TM on the incorpora- 
tion  of 3Hrpalmitate into  protein  (solid bar) and  lipid  (shaded 
bar), The left bar of  each pair represents TM inhibition of total cel- 
lular incorporation, and the right bar represents inhibition of label- 
ing measured in the presence of  cycloheximide. Each bar represents 
labeling in the presence of 10 t~g/mi  TM, expressed as a percentage 
of labeling in corresponding cultures in the absence of TM. Label- 
ing of SNAP-25, the prominent  substrate protein migrating close 
to  the  27.5 kD  standard  was  used  for quantitation  of protein 
palmitoylation  in this  and  all  following experiments  with  PC12 
cells.  Label co-migrating  with the phosphatidylcholine  standard 
was used to quantitate incorporation of fatty acid into lipid. Results 
are the means  +  standard error for seven (protein) or four (lipid) 
independent experiments. (C) Dose dependency and time course of 
TM inhibition of protein palmitoylation.  The dose dependency of 
TM inhibition  is expressed  as a percent  of control  labeling  (no 
TM).  Results are the means  5:  SD for four independent  experi- 
ments, and were obtained in the absence of cycloheximide. The in- 
set illustrates the time-course of  onset of  TM inhibition of  palmitoy- 
lation in the presence  of cycloheximide. A series of cell cultures 
were labeled with [3H]palmitate for up to 40 min (open circles); 
at 20 min, 10 #g/ml TM was added to some cultures (arrow) and 
labeling  was  then  continued  for an  additional  20  min  (closed 
squares). Triplicate cultures were removed at 5-rain intervals for 
analysis of palmitate incorporation into protein, and the results are 
plotted in arbitrary densitometry units. Solid lines indicate the best- 
fit least-squares regression lines for labeling in the presence and ab- 
sence ofTM (r = 0.94 and 0.66 for control and TM treated respec- 
tively, Statview II, Abacus Concepts Inc.). 
of 30 min or more (Heacock, 1982; Takatsuki and Tamura, 
1971),  and the effect of TM on glycosylation is maintained 
in the presence of serum and for a long period after removal 
of TM (Fichard et al.,  1990). In contrast, the rapid collapse 
of growth cones and cessation of neurite extension,  within 
minutes of TM addition, requires serum-free medium and is 
readily reversed by washout of TM or by addition of serum 
in the continued presence of TM (Fig. 5). The rapid inhibi- 
tion of ongoing protein palmitoylation offers one plausible 
mechanism for the rapid and reversible disruption of growth 
cones functions by TM. 
TM Inhibition of Palmitoylation Can Be Distinguished 
from Effects on Glycosylation 
It would be useful to have more definitive criteria to assess 
whether growth cone collapse and cessation of neurite elon- 
gation after TM treatment are due to the inhibition of protein 
acylation. The hypothesis that TM acts as a competitive ana- 
log of  long-chain fatty acyl-CoA (Fig. 1 A) predicts two prop- 
erties that could be used to distinguish TM inhibition of pro- 
tein palmitoylation from other actions of the drug, including 
its established actions on protein glycosylation. 
The first distinction is based on the existence of a  series 
of closely related TM homologues.  These homologues all 
share the general structure illustrated in Fig. 1 A, except that 
each homologue contains a  different fatty acyl side-chain. 
Fractionation of TM by side-chain length produces four fam- 
ilies of homologues, with hydrocarbon chains ranging from 
14 carbons (TM-A) to 17 carbons (TM-D). Each family con- 
tains several homologues that vary in the degree of saturation 
and branching of the hydrocarbon chain (Mahoney and Duk- 
sin, 1980; Takatsuki et al.,  1979). Because posttranslational 
protein acylation exhibits a strong selectivity for fatty acids 
containing  16  or  more carbon atoms  (Buss  et  al.,  1984; 
Grand,  1989;  James and Olson,  1990;  Olson et ai.,  1985; 
Schmidt  and Burns,  1989;  Wilcox and  Olson,  1987),  the 
shorter-chain homologues of TM would be expected to be 
poor competitive inhibitors of protein acylation. We there- 
fore separated commercial preparations of TM into the con- 
stituent  homologue families (Mahoney and Duksin,  1980, 
and see Fig. 9 B) and compared the ability of each fraction 
to inhibit protein acylation and to produce growth cone col- 
lapse.  As predicted,  the longer-chain fractions TM-C (16- 
carbon  side-chains)  and  TM-D  (17-carbon  side-chains), 
were much more potent inhibitors of protein palmitoylation 
than the shorter chain families, A and B (14- and 15-carbon 
side-chains,  respectively; Fig.  6 A). 
If TM inhibition of protein palmitoylation is due to com- 
petition with the acyl-CoA donor, it also should be possible 
to reverse that inhibition by increasing the local intracellular 
concentration of paimitoyl-CoA. Although  exogenous pal- 
mitoyl-CoA does not cross cell membranes, we attempted to 
increase intracellular palmitoyl-CoA levels by adding a large 
amount of exogenous palmitic acid. PC12 cells were treated 
with  10 #g/ml TM in the presence of 1-100 izM palmitate 
(Fig.  6 B).  The higher doses of fatty acid significantly at- 
tenuated the inhibition of protein palmitoylation produced by 
TM (P <  0.05,  1 vs.  100 #M palmitate).  TM inhibition of 
protein glycosylation was unaffected under these conditions 
(P > 0.05), indicating that the highe~ concentrations of exog- 
enous fatty acid did not interfere with cellular uptake of TM. 
These biochemical data show that selective inhibition of 
The Journal of Cell Biology, Volume 124, 1994  526 Figure 4.  TM causes a rapid and reversible collapse and retraction of growth cones. Differentiated PC12 cell growth cones were followed 
by time lapse video microscopy before and after treatment with 10 #g/ml TM (added at time 0'). (A) In the continuous presence of TM, 
forward growth quickly stops, followed by collapse of the growth cone to a bright rounded retraction profile and physical withdrawal of 
the growth cone over a substantial distance. (B) A lO-min treatment of the growth cone prevents forward growth and initiates the rounding 
up before collapse, but washout of the drug (at time 109 results in a rapid recovery of morphology and forward growth. Bar,  10 gin. 
Patterson and Skene  Protein Palmitoylation  in Growth  Cone Function  527 Figure  5.  The  rapid  collapsing  effects  of  TM are  quickly  reversed  by  addition  of  serum.  A differentiated  PC12  cell  growth  cone  was  treated 
with 10/~g/ml  TM  at  time  0',  followed  by addition  of  10% horse  serum at  5 min Between 6 and 10  win after  the  addition  of  TM  the 
growth cone  retracted  substantially,  requiring  a  frame  shift  between  these  images.  By 15  min  after  the  addition  of  serum, the  growth  cone 
is  clearly  re-eastablishing  itself,  and grows forward  rapidly  over  the  next  30 min in  the  continuous  presence  of  TM. Bar,  10  ~m. 
protein acylation by long-chain TM homologues, and rever- 
sal of this inhibition by exogenous palmitate, provide two 
criteria that can be used to distinguish  cellular effects at- 
tributable to disruption of protein palmitoylation from those 
due to inhibition of glycosylation. Still photography of living 
cultures allowed us to evaluate the morphological responses 
of growth cones to TM in the same PC12 cell cultures used 
for the biochemical analyses. With regard to both criteria, 
morphological growth cone collapse was closely correlated 
with the inhibition of protein palmitoylation (Fig.  7).  The 
short-chain A series of TM homologues, which include po- 
tent glycosylation inlfibitors (Duksin and Maboney,  1982), 
evoked no apparent growth cone collapse (Fig. 7 A); the B 
series of homologues produced less extensive morphological 
Figure 6. TM effects on protein palmitoylation can be distinguished 
from inhibition of glycosylation. (A) Structural dependence of TM 
inhibition. PC12 cells were labeled with pH]palmitate in the pres- 
ence of whole TM or TM homologues containing fatty acyl side 
chains  of 14  (A), 15  (B),  16  (C),  or  17  (D)  carbons.  Protein 
palmitoylation  is  expressed  as  a  percentage  of the  labeling  in 
vehicle-treated control cultures. Results are the means +  range for 
two  independent  experiments.  (B)  Reversal  by exogenous  fatty 
acid. Incorporation of [3H]palmitate (solid bars) and 3H-mannose 
(shaded bars) into PC12 cell proteins was measured in the presence 
and absence of TM (10/tg/rnl)  at three concentrations of palmitic 
acid. Protein labeling in the presence of TM is expressed as a per- 
centage of control labeling at the same concentration  of palmitic 
acid. TM inhibition of  palmitoylation is largely reversed by increas- 
ing concentrations of exogenous palmitate, while the inhibition of 
glycosylation is not statistically different at different palmitate con- 
centrations. Results are means +  SD for three independent experi- 
ments. 
The Journal of Cell Biology, Volume 124, 1994  528 Figure  7,  Collapse of PC12 cell growth cones is selective  for long-chain bomologues of TM, and is reversed  by palmitate.  (A) Long 
chain TM homologue families  selectively  collapse growth cones. Phase-contrast photographs taken 15 rain after the addition  of vehicle 
(NaOH, final concentration 0.5 raM, Con) or the individual  TM fractions (10 t~g/ml) to cultures in one of the experiments  quantitated 
in Fig. 6 A. Large anc~s mark characteristic growth cone profiles, which are dark and spread in the absence of TM, but form characteristic 
phase-bright collapsed profiles  after addition of TM (small arrows).  Note the increased appearance of collapsed growth cones with the 
longer-chain TM homologues, and the appearance of varicosed processes after treatment with TM-C and D. (B) Exogenous palmitic acid 
attenuates  the effect of TM on growth cone morphology. Cells from cultures  quantitated  in Fig. 6 B were treated  without (top)  or with 
(bottom)  10/~g/ml TM in the presence of 1 #M (left) or 100 #M (right) palmitate,  and photographed after 15 rain. The overall occurrence 
of  TM-collapsed growth cones (small arrows) was reduced in the presence of  the higher concentration of  palmitate,  and more spread growth 
cones (/arge arrows) were observed. There is also a more frequent occurrence of varicosed processes after treatment with TM in the pres- 
ence of the lower concentration of palmitate.  Bars,  25 #m. 
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chain C and D series of homologues, which were the most 
potent inhibitors of protein palmitoylation, elicited a more 
pronounced collapse of PC12 cell growth cones than unfrac- 
tionated TM applied at the same concentration (10 #g/mi, 
Fig. 7 A). 
Exogenously applied palmitic acid also appeared to at- 
tenuate growth cone collapse induced by TM (Fig. 7 B), de- 
spite an increase in collapse evoked by high concentrations 
of exogenous fatty acid alone.  Counts of rounded or col- 
lapsed growth cone profiles in PC12  cell cultures showed 
that, at a concentration of only 1/~M exogenous palmitate, 
TM increased the frequency of collapsed growth cones from 
7% in the absence of TM to 93%  15 min after addition of 
10 #g/ml TM.  When the same concentration of TM was 
added in the presence of I00/~M palmitic acid, only 59% 
of growth cones exhibited a collapsed morphology. This at- 
tenuation of TM-induced growth cone collapse occurred de- 
spite some adverse responses of growth cones to high con- 
centrations of exogenous fatty acid alone (36 % collapsed in 
the absence of TM). 
These initial observations of PC12 cells indicate that TM- 
induced growth cone collapse can be dissociated from TM 
effects on glycosylation, but is tightly linked to the inhibition 
of  protein palmitoylation. This in turn suggests that dynamic 
protein palmitoylation is required for some steps in growth 
cone activity and, by implication, in neurite elongation. 
TM Impairs Axon Regeneration by Primary Neurons 
To explore more fully the potential role of dynamic protein 
palmitoylation in neurite growth, we used time-lapse video 
analysis of DRG neurons in vitro. Despite their utility for 
biochemical studies, PC12 cells do not adequately reflect 
some  biologically  important  forms  of  axon  elongation. 
When DRG neurons are axotomized to elicit axon regenera- 
tion in vivo and are subsequently explanted to tissue culture, 
the cultured neurons uniformly exhibit a rapid regrowth of 
neurites that can extend for several millimeters in vitro. The 
elongation rate and lengths of these neurites resembles the 
regeneration of axons in vivo, which is accompanied by in- 
duction of the major palmitoylated growth cone protein, 
GAP-43  (Basi et al.,  1987; Hoffman, 1989;  Schreyer and 
Skene, 1991) and a partial reduction in expression of SNAP- 
25 (Redshaw and Bisby,  1985).  Thus, cultured adult DRG 
neurons more accurately reflect aspects of axon growth re- 
quired for de novo pathway formation and nerve regeneration 
in vivo, and their rapid growth in vitro allows a more rapid 
and unambiguous quantitation of effects  on growth cone 
function than with PC12 cells. 
We used time-lapse video microscopy to select vigorously 
extending growth cones in DRG cultures and to examine the 
effects  of TM  on  their  morphology and  growth.  These 
growth cones responded to addition of TM with rapid mor- 
phological collapse, cessation of forward growth, and retrac- 
tion,  followed by morphological and  functional recovery 
upon washout of the drug (Fig. 8 A). Movements of growth 
cone filopodia and the rapid, bidirectional transport of vesi- 
cles within the regenerating neurites (Hollenbeck and Bray, 
1987) continued at concentrations of TM required to bring 
about growth cone collapse. 
At a given concentration of TM, DRG growth cones typi- 
cally respond more quickly than those of PC12 cells. This 
may indicate that the growth cones of more rapidly elongat- 
ing neurites are more susceptible to the effects of TM. Re- 
sponses to TM were apparent within 3-5 min of  application, 
even in growth cones up to 2.4 mm from the neuron cell bod- 
ies, at the ends of the longest DRG neurites examined. This 
suggests that the effects of TM are unlikely to be due to dis- 
ruption of protein synthesis or glycosylation in the neuron 
cell bodies.  Furthermore, DRG growth cone morphology 
and neurite extension were maintained for at least 2 h in the 
presence of cycloheximide (Fig. 8 B and additional data not 
shown) to inhibit protein synthesis and thus glycosylation. 
Both the TM-induced collapse of growth cones and subse- 
quent recovery can occur in the continuous presence of cy- 
cloheximide (Fig. 8 B) and are thus independent of de novo 
protein synthesis. 
Requirement for Dynamic Protein Palmitoylation  in 
Axon Regeneration 
Late posttranslational protein palmitoylation has been mea- 
sured in DRG neurons, and the two most prominent proteins 
labeled by incorporation of [3H]-palmitate  have been iden- 
tified on two-dimensional gels  as  GAP-43  and SNAP-25 
(Hess et al., 1993). Due to the small number of cells in pri- 
mary DRG cultures compared with PC12 cultures, extensive 
biochemical characterization of the TM effect on DRG neu- 
rons has not been carried out. Palmitoylation of both major 
substrate proteins, however, is strongly inhibited by 10/zg/ml 
TM (Fig. 2) in either the presence or absence of cyclohexi- 
mide (data not shown). To determine whether the inhibition 
of ongoing protein palmitoylation is responsible for the dis- 
ruption of axon regeneration by TM, we explored the struc- 
tural dependence of the growth cone responses and their 
reversal by exogenous palmitate. 
Time-lapse video microscopy of DRG neurites permitted 
us to observe the morphologies of individual DRG growth 
cones and to evaluate individual neurite elongation before 
and after application of TM. For structure:function analysis, 
all TM homologues of known structure were screened at 
different concentrations for their ability to impair growth 
cone activity. In these assays, each growth cone that stopped 
elongating after application of TM also exhibited morpho- 
logical collapse. However, at sub-maximal concentrations of 
each homologue, we often observed signs of morphological 
collapse in growth cones that continued elongating during 
the 10-20-rain assay period. To compare the efficacy of in- 
dividual TM homologues on growth cone activity, we ex- 
pressed the potency of each homologue as the percent of ac- 
tive growth cones that both collapsed and ceased forward 
growth in the 10-20 rain period immediately following ap- 
plication at different concentrations (Fig. 9 A). The poten- 
cies of the individual homologues sorted according to acyl 
chain length, with relatively little variation among individual 
members of each family. The long-chain C  and D  homo- 
logues were, on average, an order of magnitude more potent 
than the shorter-chain A  and B homologues. Whole TM, 
containing a mixture of all homologues (see Fig. 9 B), gave 
an intermediate effect in this assay (Fig. 9 A). 
The structure:function relationship of these TM homo- 
logues with regard to growth cone inhibition is clearly dis- 
tinct from that described previously for protein glycosylation 
and synthesis. In particular, inhibition of glycosylation and 
protein synthesis exhibit no systematic variation with chain 
The Journal of Cell Biology, Volume  124, 1994  530 Figure 8. TM causes a rapid, reversible collapse of regenerative DRG growth cones, even in the absence of protein synthesis. (A) Addition 
of 5/zg/ml TM (at time 0') to cultures of adult DRG neurons causes rapid collapse and retraction.  After 13 rain the TM is washed out. 
After retracting further in the ensuing few minutes, the growth cone re-establishes  and extends at a rate comparable with that observed 
before TM treatment. (B) In the continuous  presence of 100/~g/ml cycloheximide to inhibit  protein synthesis, a DRG growth cone extends 
actively until addition ofTM. Upon treatment with 1/~g/ml TM-C2, the rapid extension of this growth cone is arrested  for 20 rain. When 
the C2 homologue is replaced by a shorter-chain  homologue (B0 at much higher concentration (10/zg/ml),  the growth cone recovers and 
rapidly extends for at least 40 min. Bar,  10 #m. 
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Figure 9.  Potency of purified TM homologues on DRG growth 
cones sorts according to acyl chain length. (,4) Actively extending 
DRG growth cones were followed  by time-lapse video microscopy 
before and after treatment with purified TM homologues  at concen- 
trations between 0.5 and 10 ~,g/ml. The percentage of  growth cones 
exhibiting morphological  collapse and cessation of forward growth 
at each concentration is plotted for each homologue. The data rep- 
resent the results from 19 growth cones in seven separate cultures 
(whole-TM),  11  growth cones in  six cultures (A0,  13  growth 
cones in eight cultures (As), nine growth cones in five cultures 
(BI), eight growth cones in five  cultures 032), 24 growth cones in 
six cultures (B3), 26 growth cones in I1 cultures (CO, 19 growth 
cones in 11 cultures (C2), 25 growth cones in 10 cultures (DO, and 
12 growth cones in 8 cultures (D2). (B) Representative prepara- 
tive-HPLC trace of homologue separation (0.5 mg whole TM 
loaded), with previously identified homologues marked. 
length (Duksin and Mahoney, 1982;  Duksin et al.,  1982). 
Furthermore, growth cones that have been collapsed by a 
long-chain TM homologue can recover in the presence of 
shorter-chain homolognes and continue growing for several 
hours (Fig. 8 B and further data not shown). The structural 
requirements for TM effects on growth cone collapse, there- 
fore, are well correlated with the predicted and observed or- 
der of  potency for the inhibition of protein acylation, but not 
with the other known biochemical actions of these com- 
pounds. 
To quantitate the ability of exogenous fatty acid to attenu- 
ate the effects of TM on DRG neurite extension, we used 
video microscopy to analyze the responses of a large number 
of DRG growth cones to TM in the presence or absence of 
exogenously applied palmitic acid. The frequency of sponta- 
neous stopping was not statistically different in the presence 
or absence of exogenous palmitate. We used a dose of TM 
(2/zg/ml) which, in the absence of added paimitate, stopped 
growth in 60%  of the neurites observed (Fig.  10). In the 
presence of 30/zM palmitate, only 18%  of growth cones 
stopped growing within 20 rain after treatment with the same 
dose of TM.  This is the same frequency at which growth 
cones exhibited spontaneous cessation of growth during a 
20-rain control observation period,  before treatment with 
TM (Fig.  10). 
Discussion 
The results show that some homologues of tunicamycin can 
inhibit the dynamic posttranslational fatty acylation of pro- 
teins in intact cells.  The ability of TM to inhibit protein 
palmitoylation  in  a  cell-free  acyltransferase  preparation 
shows that the inhibition of protein fatty acylation is a direct 
action of TM, and not a secondary consequence of the well- 
established effects of TM on N-linked glycosylation  and pro- 
tein synthesis. The precise mechanism by which TM homo- 
logues inhibit protein palmitoylation is not known, but the 
preferential inhibition by long-chain TM homolognes, and 
the ability of excess palmitoyl-CoA to reverse this inhibition 
in a cell-frec assay, are consistent with a model in which TM 
competes with fatty acyl-CoA substrates for binding to one 
or more protein acylating enzymes. Reversible inhibition of 
protein long-chain acylation establishes a new biochemical 
action of TM that can be exploited to investigate the biologi- 
cal roles of this dynamic protein modification in various eu- 
karyotic cells. 
In the past, TM has been used extensively to implicate 
protein glycosylation in a variety of viral and cellular func- 
tions. The present findings suggest that some TM-sensitive 
functions might profitably be reexamined to assess whether 
they reflect biological roles of protein palmitoylation rather 
than glycosylation. Similarly, TM may also prove to be a 
useful tool for exploring the functional sequelae of  posttrans- 
lationai palmitoylation of proteins such as ion channels and 
cell-surface receptors (Kamik et al., 1993; Mouillac et al., 
1992;  Schmidi and  Catterall,  1987),  heterotrimeric  and 
small GTP-binding proteins (Adamson et al., 1992a; Kuroda 
et al., 1993; Magee et al., 1987; Parenti et al., 1993), Golgi 
and vesicular proteins (Hess et al., 1992; Mundy and War- 
ren,  1992;  Stllner et al.,  1993;  Siidhof and Jahn,  1991), 
chloroplast photosystem components (Mattoo and Edelman, 
1987),  and other substrates in a variety of eukaryotic ceils. 
Although the naturally occurring homologues of TM appear 
to provide a valuable set of  cell-permeable probes for explor- 
ing the biological roles of protein fatty acylation, all known 
homologues of TM also inhibit N-linked glycosylation  at the 
concentrations examined here. However, the rapidity of the 
inhibition, its preferential expression in the posttranslational 
component,  the  selective  inhibition of palmitoylation by 
long-chain TM homologues, and its reversal by exogenous 
fatty acids, all provide an initial set of criteria to distinguish 
biological effects attributable to protein acylation from those 
due to glycosylation. The TM molecule, furthermore, may 
serve as a reference compound for the design of more selec- 
tive inhibitors of protein long-chain acylation. 
In neurons, TM produces a rapid and reversible collapse 
of growth cones and cessation of neurite extension. These 
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tenuates the effects  of TM on DRG 
growth  cones.  (A)  Representative 
video flames illustrating net growth 
of DRG neurites during 20 rain pe- 
riods  before  and  after  addition  of 
2 #g/ml TM. In the absence of exog- 
enous palmitate (left), a growth cone 
extends rapidly before the addition of 
TM,  and  ceases  forward extension 
after  addition  of  drug.  A  second 
growth cone growing in from the bot- 
tom of the flame also exhibits mor- 
phological collapse, but continued to 
extend in the presence of TM. In the 
presence  of  palmitate  (r/ght),  a 
growth cone continues to extend af- 
ter TM addition. (B) Quantitation of 
growth in the presence or absence of 
TM and palmitate. Net elongation of 
individual DRG neurites was recorded 
in the presence or absence of 30 #M 
palmitate for 20-min periods before 
and after addition of 2 #g/ml TM, as 
in A.  The percentage of neurites ex- 
hibiting net elongation in each obser- 
vation period is plotted. In the absence 
of exogenous palmitate (left), the ad- 
dition  of TM  substantially  reduced 
the number of elongating neurites (P 
< 0.002, Student's unpaired t~o-tailed 
t-test). In the presence of added pal- 
mitate, the same dose of  TM failed to 
reduce the number of  elongating neu- 
rites (P >  0.05).  The percentage of 
elongating  neurites  was determined 
in  four  separate  cultures  for  each 
condition  (24-77  neurites  per  cul- 
ture), and the bars indicate the means 
+  SD for the four experiments. A to- 
tal of 159 and 166 growth cones were 
analyzed in the absence or presence 
of palmitate respectively. Bar,  10 #m. 
effects cannot  be  explained  by the  previously documented 
effects of TM on protein synthesis and glycosylation. Neither 
cycloheximide,  an inhibitor of protein  synthesis,  nor treat- 
ment with short-chain homologues of tunicamycin, which in- 
elude  potent  inhibitors  of glycosylation,  mimics  the  rapid 
effects  of whole  TM  on  neuronal  growth  cones.  Further- 
more, if growth cone collapse resulted from depletion of gly- 
coproteins or other proteins required  for elongation,  recov- 
ery  of  function  should  require  protein  synthesis  and 
glycosylation,  which  is  tightly  linked  to protein  synthesis 
(Elbein,  1984; Hemming, 1982).  Yet growth cones that have 
collapsed in response to TM are able to recover normal mor- 
phology  and  resume  rapid  neurite  elongation  in  the  con- 
tinued  presence  of  cycloheximide  and  short-chain  homo- 
logues  of  TM.  Finally,  TM  is  an  effective  inhibitor  of 
glycosylation in the presence of serum in many different cell 
types, including cultured neurons (Heacock,  1982) and neu- 
ral tumor cell lines (Richter-Landsberg and Duksin,  1983), 
but the growth cone responses  to TM are rapidly reversed 
by serum. 
On the other hand,  both the structural  requirements  and 
the  sensitivity  to exogenous  fatty acid  of the  growth  cone 
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competitive  inhibition  of  protein  palmitoylation.  Struc- 
ture:function analysis with 10 individual homologues of TM 
showed that the ability to alter growth cone activity depends 
on the length of the fatty acyl moiety of tunicamycin; TM 
homologues with side-chains of 16 carbons or more are po- 
tent inhibitors of neurite extension, while the shorter 14- or 
15-carbon homologues are consistently less potent. This bi- 
modal segregation is predicted for competitive inhibition of 
protein palmitoylation by TM, based on the reported ability 
ofpalmitoylating activities in a variety of cell types to recog- 
nize palmitoyl-CoA (16 carbon atoms) and a variety of other 
long-chain acyl-Cogs, but not myristoyl-CoA (14 carbon 
atoms).  The  systematic  dependence  of growth  cone  re- 
sponses on the fatty acyl chain length of TM homologues 
also  is  well  correlated  with  the  observed  inhibition  of 
palmitoylation by the homologue families. 
The most compelling evidence that growth cone collapse 
and retraction are due to TM inhibition of protein palmitoy- 
lation is the ability of exogenous fatty acid to attenuate or re- 
verse these effects. Although the intracellular levels of free 
fatty  acid  and  acyl-CoA  are  low  and  strongly  buffered 
(Arduini et al., 1992; Molaparast-Saless et al., 1988), high 
concentrations of exogenous palmitic acid should produce at 
least  a  transient  increase  in  intracellular palmitoyl-CoA, 
which is predicted to compete with TM for binding to pro- 
tein fatty acyltransferases. Direct labeling studies in PC12 
cells confirm that exogenous fatty acid can reverse TM inhi- 
bition of  protein palmitoylation without preventing TM inhi- 
bition of protein glycosylation. Still photography of PC12 
cells, and more quantitative video analysis of DRG growth 
cones, show that the disruption of growth cone functions by 
TM  is  largely  or  completely  attenuated  by  exogenous 
palmitic acid. The ability of elevated fatty acid levels to re- 
verse the TM inhibition of protein palmitoylation might also 
account for the reversibility of growth cone collapse in the 
presence  of serum,  which contains lipoproteins and free 
fatty acids. 
The characteristics of TM inhibition of neuronal growth 
cone functions, therefore, are not explained by previously 
documented effects  of TM on N-linked glycosylation and 
protein synthesis, but are consistent with the predicted and 
observed properties of TM-mediated inhibition of protein 
palmitoylation. The rapid collapse of growth cones and inhi- 
bition of neurite elongation when palmitoylation is inhibited 
implies that ongoing fatty acylation of growth cone proteins 
is important for one or more steps  in normal growth cone 
functions and neurite extension. 
Advancing growth cones mediate cycles of filopodial or 
lamellipodial extension,  followed by consolidation of se- 
lected filopodia by the assembly of membrane and cytoskel- 
etal  elements transported  from the  neuronal soma.  Time 
lapse observations evince0~continued  rapid axonal transport 
in neurites (data not shown) and active extension and retrac- 
tion of filopodia during TM-induced collapse and retraction. 
This indicates that the effects of TM did not arise from a 
gross disruption of the supply of raw material for neuritic as- 
sembly, or from general disruption of actin-based motility. 
The rounding of growth cones and the formation of varicosities 
early in the response to TM are consistent with a disruption 
of  membrane-cytoskeletal interactions involved in maintain- 
ing cell shape, or with a loss of adhesion to the substratum. 
It is not clear from the present data which protein sub- 
strates for palmitoylation may be most important for normal 
growth cone activity and neurite elongation. The most prom- 
inent substrate for palmitoylation in isolated growth cones 
(Skene and Virag, 1989), and one of  the most prominent sub- 
strates in intact DRG neurons (Hess et al., 1993), has been 
identified as GAP-43. GAP-43 is an abundant constituent of 
growth cones, transiently expressed in most neurons during 
developmental axon outgrowth and reinduced during nerve 
regeneration (Skene, 1989).  The most prominent substrate 
for palmitoylation in PC12 cells, and a second major sub- 
strate in DRG neurons is SNAP-25,  a component of mature 
synaptic terminals that also has been proposed to play an im- 
portant role in late stages of axon growth and synaptogenesis 
during development (Osen-Sand et al.,  1993;  Oyler et al., 
1991; S/511ner et al., 1993). The prominence of these proteins, 
however,  does not exclude the possibility that TM-induced 
growth cone collapse results from interference with dynamic 
palmitoylation of additional, less prominent substrates. Pro- 
teins known to be palmitoylated in different cell types in- 
clude several other proteins involved in vesicle trafficking 
(Adamson et al., 1992a; Adamson et al., 1992b; Cheng and 
Reese,  1987; Hancock et al.,  1990;  Pfanner et al.,  1989; 
S511ner et al.,  1993;  Stidhof and Jahn,  1991); membrane 
receptors  (Bourguignon et al.,  1991; Moss  et al.,  1990; 
Wellner et al., 1987) and ion channels (Okubo et al., 1991; 
Schmidt and Catterall, 1987); and proteins involved in mem- 
brane-cytoskeleton interactions such as vinculin (Burn and 
Burger,  1987),  ot-actinin  (Burn  et  al.,  1985;  Sobue  and 
Kanda,  1989),  ankyrin (Bourguignon et  al.,  1991), p41 
(Schneider et al., 1988), p55 (Ruff et al., 1991), and p21rac 
(Ridley et al.,  1992;  Newman and Magee,  1993).  It is not 
known  which  of  these  or  other  substrates  are  actively 
palmitoylated during elongation of intact neuronal growth 
cones, but evidence for multiple palmitoylated substrates in 
other cells suggests that the contribution of dynamic protein 
palmitoylation to neurite growth may reflect pleiotropic ac- 
tions of palmitoylating enzymes on several steps in growth 
cone advance. 
An important role for ongoing protein palmitoylation in 
growth cone functions implies that the biochemical control 
of this modification, including extracellular signals that im- 
pinge on acylation (Huang, 1989; James and Olson,  1989; 
Jochen et al.,  1991; Mouillac et al.,  1992),  would have a 
significant effect on nerve growth in development or regener- 
ation. Although it is not yet clear how palmitoyIation  is regu- 
lated in vivo, growth cones are the targets for a broad array 
of cues in their local environment that control and direct 
axon elongation. Dynamic cycles of protein acylation and 
deacylation now can be viewed as one potential site of action 
of  naturally occurring ligands proposed to guide or modulate 
axon extension through a mechanism that produces localized 
growth cone collapse (Caroni and Schwab,  1988;  Harris et 
al., 1987; Keynes and Cook, 1990; Lohofet  al., 1992; Raper 
and Grunewald, 1990; Sretavan and Reichardt, 1993; Walter 
et al.,  1990).  Thrombin, for example, which modulates cy- 
cles of protein palmitoylation and deacylation in platelets 
(Huang, 1989),  is found in the developing brain (Dihanich 
et al., 1991) and has been reported to bring about the rapid 
and reversible collapse of neuronal growth cones (Jalink and 
Moolenar, 1992; Suidan et al., 1992). Apolipoprotein E and 
lipoproteins containing this apoprotein also are extremely 
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ing nerves, where they can direct the receptor-mediated up- 
take of free fatty acids and fatty acyl esters into growth cones 
(Block and Pletscher, 1988; Ignatius et al., 1987; Skene and 
Virag,  1989).  ApoE-containing lipoproteins also have been 
shown to influence the rate, extent, and branching pattern of 
neurite  outgrowth  by  DRG  neurons  (Handelmann  et  al., 
1992). Finally, we have found that nitric oxide can interfere 
with protein palmitoylation and also produces a rapid and re- 
versible collapse  of neuronal  growth  cones  (Hess  et  al., 
1993).  The ability of these molecules to influence protein 
palmitoylation may in some cases contribute to their regula- 
tory influences on neurite growth. 
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